Marijuana use and motor vehicle crashes

Epidemiologic Reviews

Volumn 34, Issue 1, 2012, Pages 65-72

  Li, Mu Chen ^a   Brady, Joanne E ^a,b   DiMaggio, Charles J ^a,b   Lusardi, Arielle R ^a   Tzong, Keane Y ^a   Li, Guohua ^a,b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b Columbia University Mailman School of Public Health ^*  (United States)

Author keywords

accidents, traffic; automobiles; cannabis; motor vehicles; substance abuse detection

Indexed keywords

CANNABIS; TETRAHYDROCANNABINOLIC ACID;

ARTICLE; CINAHL; COCHRANE LIBRARY; DRIVING ABILITY; EFFECT SIZE; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; SELF REPORT; SUBSTANCE ABUSE; TRAFFIC ACCIDENT; TRAFFIC SAFETY; URINE;

ACCIDENTS, TRAFFIC; ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MARIJUANA SMOKING; MIDDLE AGED; MINORITY HEALTH; SUBSTANCE ABUSE DETECTION; YOUNG ADULT;

EID: 84862908467     PISSN: 0193936X     EISSN: 14786729     Source Type: Journal    
DOI: 10.1093/epirev/mxr017     Document Type: Article

References (78)

1. Controlled Substances Act, 21 USC §801. 2007. (http://www. deadiversion.usdoj.gov/21cfr/21usc/801.htm). (Accessed August 2, 2011).
2. Yarett I. How high are you? Newsweek. 2010;155(7):56.
3. 15 Legal medical marijuana states and DC: laws, fees, and possession limits. Santa Monica, CA: ProCon.org (http://medicalmarijuana.procon.org/view. resource.php?resourceID=000881). (Accessed December 16, 2010).
4. Ndetei DM, Arboleda-Flórez J, Gawad T. Forum: decriminalization versus criminalization of cannabis. CurrOpin Psychiatry. 2008;21(2):127-128. (Pubitemid 351339863)
5. Cohen PJ. Medical marijuana: the conflict between scientific evidence and political ideology. Part one of two. J Pain Palliat Care Pharmacother. 2009;23(1):4-25.
6. Reinarman C, Cohen PD, Kaal HL. The limited relevance of drug policy: cannabis in Amsterdam and in San Francisco. Am J Public Health. 2004;94(5):836-842. (Pubitemid 38560392)
7. Medical marijuana on trial. Lancet Oncol. 2001;2(5):251.
8. Martin BR. Medical marijuana - moving beyond the smoke. Lancet. 2002;360(9326):4-5. (Pubitemid 34756484)
9. Christenson V. Courts protect Ninth Circuit doctors who recommend medical marijuana use. J Law Med Ethics. 2004;32(1):174-177. (Pubitemid 39099126)
10. Hoffmann DE, Weber E. Medical marijuana and the law. N Engl J Med. 2010;362(16):1453-1457.
11. Controlled Substances Act, 21 USC §812. 2007. (http://www. deadiversion.usdoj.gov/21cfr/21usc/812.htm). (Accessed August 2, 2011).
12. Gathering the evidence on medical marijuana. Nature. 2001;410(6829):613.
13. Cohen PJ. Medical marijuana 2010: it's time to fix the regulatory vacuum. J Law Med Ethics. 2010;38(3):654-666.
14. Chang AE, Shiling DJ, Stillman RC, et al. Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation. Ann Intern Med. 1979;91(6):819-824. (Pubitemid 10182651)
15. Rog DJ, Nurmikko TJ, Friede T, et al. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology. 2005;65(6):812-819. (Pubitemid 41362120)
16. Rog DJ, Nurmikko TJ, Sarantis NS, et al. A long-term open-label trial of safety and efficacy of Sativex®, a cannabis based medicine, in central neuropathic pain due to multiple sclerosis. J Neurol. 2006;253(suppl 2):S100.
17. Zajicek J, Fox P, Sanders H, et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. UK MS Research Group. Lancet. 2003;362(9395):1517-1526. (Pubitemid 37410189)
18. Zajicek JP, Sanders HP, Wright DE, et al. Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. J Neurol Neurosurg Psychiatry. 2005;76(12):1664-1669. (Pubitemid 41697631)
19. Duran M, Pérez E, Abanades S, et al. Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. Br J Clin Pharmacol. 2010;70(5):656-663.
20. Ware MA, Wang T, Shapiro S, et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ. 2010;182(14):E694-E701.
21. Martín-Sánchez E, Furukawa TA, Taylor J, et al. Systematic review and meta-analysis of cannabis treatment for chronic pain. Pain Med. 2009;10(8):1353-1368.
22. Abrams DI, Jay CA, Shade SB, et al. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology. 2007;68(7):515-521.
23. Chang AE, Shiling DJ, Stillman RC, et al. A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy. Cancer. 1981;47(7):1746-1751. (Pubitemid 11145826)
24. Ellis RJ, Toperoff W, Vaida F, et al. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology. 2009;34(3):672-680.
25. Greenberg HS, Werness SA, Pugh JE, et al. Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers. Clin Pharmacol Ther. 1994;55(3):324-328. (Pubitemid 24183732)
26. Wilsey B, Marcotte T, Tsodikov A, et al. A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. J Pain. 2008;9(6):506-521.
27. Merritt JC, Crawford WJ, Alexander PC, et al. Effect of marihuana on intraocular and blood pressure in glaucoma. Ophthalmology. 1980;87(3):222-228. (Pubitemid 10130590)
28. Turcotte D, Le Dorze JA, Esfahani F, et al. Examining the roles of cannabinoids in pain and other therapeutic indications: a review. Expert Opin Pharmacother. 2010;11(1):17-31.
29. Barnes MP. Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain. Expert Opin Pharmacother. 2006;7(5):607-615.
30. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009;374(9698):1383-1391.
31. Moskowitz H. Marihuana and driving. Accid Anal Prev. 1985;17(4):323-345.
32. Solowij N, Stephens RS, Roffman RA, et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. Marijuana Treatment Project Research Group. JAMA. 2002;287(9):1123-1131. (Pubitemid 34252081)
33. Tashkin DP, Coulson AH, Clark VA, et al. Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis. 1987;135(1):209-216. (Pubitemid 17223915)
34. Aldington S, Williams M, Nowitz M, et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax. 2007;62(12):1058-1063. (Pubitemid 350206197)
35. Cabral GA, Dove Pettit DA. Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease. J Neuroimmunol. 1998;83(1-2):116-123. (Pubitemid 28280957)
36. Bolla KI, Brown K, Eldreth D, et al. Dose-related neurocognitive effects of marijuana use. Neurology. 2002;59(9):1337-1343. (Pubitemid 35285983)
37. Degenhardt L, Hall WD. The adverse effects of cannabinoids: implications for use of medical marijuana. CMAJ. 2008;178(13):1685-1686. (Pubitemid 351897984)
38. Wang T, Collet JP, Shapiro S, et al. Adverse effects of medical cannabinoids: a systematic review. CMAJ. 2008;178(13):1669-1678. (Pubitemid 351899653)
39. Grotenhermen F, Leson G, Berghaus G, et al. Developing limits for driving under cannabis. Addiction. 2007;102(12):1910-1917. (Pubitemid 350145667)
40. MacDonald S, Anglin-Bodrug K, Mann RE, et al. Injury risk associated with cannabis and cocaine use. Drug Alcohol Depend. 2003;72(2):99-115. (Pubitemid 37434002)
41. Sewell RA, Poling J, Sofuoglu M. The effect of cannabis compared with alcohol on driving. Am J Addict. 2009;18(3):185-193.
42. Kelly E, Darke S, Ross J. A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions. Drug Alcohol Rev. 2004;23(3):319-344. (Pubitemid 39305501)
43. Bates MN, Blakely TA. Role of cannabis in motor vehicle crashes. Epidemiol Rev. 1999;21(2):222-232. (Pubitemid 30649824)
44. Walsh JM, de Gier JJ, Christopherson AS, et al. Drugs and driving. Traffic Inj Prev. 2004;5(3):241-253. (Pubitemid 39049928)
45. Ramaekers JG, Berghaus G, van Laar M, et al. Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend. 2004;73(2):109-119. (Pubitemid 38068347)
46. Drummer OH, Gerostamoulos J, Batziris H, et al. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accid Anal Prev. 2004;36(2):239-248.
47. MacDonald S, Mann R, Chipman M, et al. Driving behavior under the influence of cannabis or cocaine. Traffic Inj Prev. 2008;9(3):190-194.
48. Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: volume I. Summary of National Findings. Rockville, MD: Department of Health and Human Services, 2010. NSDUH series H-38A, HHS publication SMA10-4856 findings. (http://oas.samhsa.gov/NSDUH/ 2k9NSDUH/2k9Results.htm#1.1). (Accessed November 1, 2010).
49. Jones RK, Shinar D, Walsh JM. State of Knowledge of Drug-Impaired Driving. Washington, DC: National Highway Traffic Safety Administration; 2003.
50. Walsh JM, Flegel R, Cangianelli LA, et al. Epidemiology of alcohol and other drug use among motor vehicle crash victims admitted to a trauma center. Traffic Inj Prev. 2004;5(3):254-260. (Pubitemid 39049929)
51. Engeland A, Skurtveit S, Mørland J. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol. 2007;17(8):597-602. (Pubitemid 47096708)
52. Smink BE, Egberts AC, Lusthof KJ, et al. The relationship between benzodiazepine use and traffic accidents: a systematic literature review. CNS Drugs. 2010;24(8):639-653.
53. Orriols L, Salmi LR, Philip P, et al. The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies. Pharmacoepidemiol Drug Saf. 2009;18(8):647-658.
54. Sansone RA, Sansone LA. Driving on antidepressants: cruising for a crash? Psychiatry (Edgmont). 2009;6(9):13-16.
55. Gustavsen I, Bramness JG, Skurtveit S, et al. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med. 2008;9(8):818-822.
56. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
57. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008- 2012. (Pubitemid 30214957)
58. Endnote (computer program). Version X3. New York, NY: Thomson Reuters; 2009.
59. Centre for Occupational and Environmental Health, University of Manchester. Critical appraisal checklist. Manchester, United Kingdom: University of Manchester, Centre for Occupational and Environmental Health, 2010. (http://www.medicine.manchester.ac.uk/oeh/undergraduate/specialstudymodules/ criticalappraisal/). (Accessed June 17, 2011).
60. Lipsey MW, Wilson D. Practical Meta-Analysis. Thousand Oaks, CA: Sage Publications; 2001.
61. Persaud R. Misleading meta-analysis. "Fail safe N" is a useful mathematical measure of the stability of results. BMJ. 1996;312(7023):125.
62. Mann RE, Stoduto G, Ialomiteanu A, et al. Self-reported collision risk associated with cannabis use and driving after cannabis use among Ontario adults. Traffic Inj Prev. 2010;11(2):115-122.
63. Movig KL, Mathijssen MP, Nagel PH, et al. Psychoactive substance use and the risk of motor vehicle accidents. Accid Anal Prev. 2004;36(4):631-636.
64. Blows S, Ivers RQ, Connor J, et al. Marijuana use and car crash injury. Addiction. 2005;100(5):605-611. (Pubitemid 40646285)
65. Woratanarat P, Ingsathit A, Suriyawongpaisal P, et al. Alcohol, illicit and non-illicit psychoactive drug use and road traffic injury in Thailand: a case-control study. Accid Anal Prev. 2009;41(3):651-657.
66. Asbridge M, Poulin C, Donato A. Motor vehicle collision risk and driving under the influence of cannabis: evidence from adolescents in Atlantic Canada. Accid Anal Prev. 2005;37(6):1025-1034. (Pubitemid 41475562)
67. Mura P, Kintz P, Ludes B, et al. Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study. Forensic Sci Int. 2003;133(1-2):79-85. (Pubitemid 36555422)
68. Brault M, Dussault C, Bouchard J, et al. The contribution of alcohol and other drugs among fatally injured drivers in Quebec: final results [abstract]. Paper presented at the 17th International Conference on Alcohol, Drugs and Traffic Safety, Glasgow, United Kingdom, August 8-13, 2004. (www.saaq.gouv.qc. ca/publications/dossiers-etudes/drogue-an.pdf). (Accessed January 14, 2011).
69. Gerberich SG, Sidney S, Braun BL, et al. Marijuana use and injury events resulting in hospitalization. Ann Epidemiol. 2003;13(4):230-237. (Pubitemid 36390345)
70. Fergusson DM, Horwood LJ. Cannabis use and traffic accidents in a birth cohort of young adults. Accid Anal Prev. 2001;33(6):703-711. (Pubitemid 32798099)
71. Alcohol and other drug use among victims of motor-vehicle crashes - West Virginia, 2004-2005. MMWR Morb Mortal Wkly Rep. 2006;55(48):1293-1296.
72. Lacey JH, Kelley-Baker T, Furr-Holden D, et al. 2007 National Roadside Survey of Alcohol and Drug Use by Drivers: Drug Results. Washington, DC: National Highway Traffic Safety Administration; 2009. (DOT HS 811 249).
73. Walsh JM, Flegel R, Atkins R, et al. Drug and alcohol use among drivers admitted to a level-1 trauma center. Accid Anal Prev. 2005;37(5):894-901. (Pubitemid 41164364)
74. O'Malley PM, Johnston LD. Drugs and driving by American high school seniors, 2001-2006. J Stud Alcohol Drugs. 2007;68(6):834-842. (Pubitemid 350144492)
75. Williams AF, Peat MA, Crouch DJ, et al. Drugs in fatally injured young male drivers. Public Health Rep. 1985;100(1):19-25. (Pubitemid 15167388)
76. Robbe H. Marijuana's impairing effects on driving are moderate when taken alone but severe when combined with alcohol. Hum Psychopharmacol. 1998;13:S70-S78. (Pubitemid 28512911)
77. Watson SJ, Benson JA Jr, Joy JE. Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report. Arch Gen Psychiatry. 2000;57(6):547-552. (Pubitemid 30349434)
78. Aggarwal SK, Carter GT, Sullivan MD, et al. Medicinal use of cannabis in the United States: historical perspectives, current trends, and future directions. J Opioid Manag. 2009;5(3):153-168.